Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.500
-0.050 (-3.23%)
Dec 12, 2025, 12:19 PM EST - Market open

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22
331597327
Market Cap Growth
16.47%-82.21%-84.31%-70.25%-
Enterprise Value
-4215--
Last Close Price
1.554.78681.446338.685983.49
PE Ratio
-2.69---
PB Ratio
0.240.40-1.39-485.51192.37
P/TBV Ratio
0.250.40--192.37
Debt / Equity Ratio
---0.95--
Quick Ratio
7.7710.550.060.8313.62
Current Ratio
8.0911.040.090.8913.90
Return on Equity (ROE)
-74.29%---468.63%-
Return on Assets (ROA)
-34.44%-54.20%-126.35%-123.25%-
Return on Capital (ROIC)
-43.55%-73.88%--295.49%-
Return on Capital Employed (ROCE)
-35.00%-54.50%25.10%1613.80%-109.20%
Earnings Yield
-131.59%37.25%-335.14%-3.29%-0.57%
FCF Yield
-141.93%-137.84%-19.33%-1.64%-0.43%
Buyback Yield / Dilution
-831.83%-1670.55%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q